HPV Vaccination
Prevent the disease before it starts. HPV vaccine is one of our most cost-effective tools against cervical cancer, protecting against at least 70% of all cervical cancers.
Prevent the disease before it starts. HPV vaccine is one of our most cost-effective tools against cervical cancer, protecting against at least 70% of all cervical cancers.
Detect early and prevent the progression of the disease. Early detection, diagnosis, and prompt treatment of precancerous lesions are crucial to driving down incidence in the next decades by preventing the development of cervical cancer.
Minimize disability and suffering. Timely availability of and access to quality, affordable treatment and palliative care can help slow the progression of cervical cancer and protect the dignity and quality of life for women living with this disease.
Prevent the disease before it starts. HPV vaccine is one of our most cost-effective tools against cervical cancer, protecting against at least 70% of all cervical cancers.
Cervical cancer is preventable and treatable, yet it is still the fourth most common cancer among women and kills over 300,000 women every year. Concerningly, significant disparities exist: over 90% of these deaths are in low-and middle-income countries.
Without action, deaths from cervical cancer are projected to increase 50% by 2040. The WHO’s Global strategy to accelerate the elimination of cervical cancer as a public health problem provides a roadmap to eliminate cervical cancer within the lifetime of today’s youngest girls.